ALNOV:EPA
Novacyt SA
0,41 €
0,00%
(0,00) 1D
6 նոյ, 17:35:21 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,41 €
High
0,41 €
Low
0,40 €
Mkt. cap
27,19 մլն
Avg. vol.
187,71 հզր
Volume
119,78 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 մլն
No. of employees
228
Open
0,41 €
High
0,41 €
Low
0,40 €
Mkt. cap
27,19 մլն
Avg. vol.
187,71 հզր
Volume
119,78 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 մլն
No. of employees
228
News stories
From web sources and news partners
Yahoo Finance
·
2 ժամ առաջ
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
WSPA 7News
·
34 րոպե առաջ
From high-flying AI stocks to tariff-hit alcohol companies, the midterms shook up Wall Street
Bloomberg.com
·
1 ժամ առաջ
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
Seeking Alpha
·
57 րոպե առաջ
Introducing The S&P 500 And HKEX Tech 100 Index: A Complementary Tech-Focused Blend
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded03 հլս, 2006 թ.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com